Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samit Ganguly

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Bioorganic & Medicinal Chemistry Letters|January 11, 2014
Thiazolopyridone ureas as DNA gyrase B inhibitors: optimization of antitubercular activity and efficacyRamesh R Kale, Manoj G Kale, David Waterson, et al.
Journal of Medicinal Chemistry|May 10, 2014
Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosisShahul Hameed P, Vikas Patil, Suresh Solapure, et al.
Journal of Medicinal Chemistry|October 4, 2013
Thiazolopyridine ureas as novel antitubercular agents acting through inhibition of DNA Gyrase BManoj G Kale, Anandkumar Raichurkar, Shahul Hameed P, et al.
The Lancet. Infectious Diseases|September 5, 2024
Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trialFlonza Isa, Ana M Gonzalez Ortiz, Jonathan Meyer, et al.
Science Translational Medicine|November 6, 2024
Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infectionChristopher D Petro, Andrea T Hooper, Avery Peace, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Bioorganic & Medicinal Chemistry Letters|January 11, 2014
Thiazolopyridone ureas as DNA gyrase B inhibitors: optimization of antitubercular activity and efficacyRamesh R Kale, Manoj G Kale, David Waterson, et al.
Journal of Medicinal Chemistry|May 10, 2014
Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosisShahul Hameed P, Vikas Patil, Suresh Solapure, et al.
Journal of Medicinal Chemistry|October 4, 2013
Thiazolopyridine ureas as novel antitubercular agents acting through inhibition of DNA Gyrase BManoj G Kale, Anandkumar Raichurkar, Shahul Hameed P, et al.
The Lancet. Infectious Diseases|September 5, 2024
Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trialFlonza Isa, Ana M Gonzalez Ortiz, Jonathan Meyer, et al.
Science Translational Medicine|November 6, 2024
Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infectionChristopher D Petro, Andrea T Hooper, Avery Peace, et al.
Pageof 3